Publications

5808 Results

Randomized Phase II Study of 2nd Line Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) vs FOLFIRI in Metastatic Pancreatic Cancer (mPC): SWOG S1513

Authors
EG Chiorean;K Guthrie;PA Philip;E Swisher;F Jalikis;M Pishvaian;J Berlin;MS Noel;JM Suga;I Garrido-Laguna;D Cardin;D Lew;A Lowy;H Hochster
Journal / Conference
J Clin Oncol 37(suppl; abstr 4014); American Society of Clinical Oncology (5/31-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1513

SWOG S1609: A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART)

Authors
S Patel;M Othus;Y Chae;F Giles;J Hayward;C McLeod;H Chen;E Sharon;E Mayerson;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
J Clin Oncol 37(suppl; abstr TPS2658); ASCO (5/31-6/4/2019, Chicago IL), TIPS, poster session
Year
2019
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Sex Differences in Adverse Event Reporting in SWOG Chemotherapy, Biologic/Immunotherapy and Targeted Agent Cancer Clinical Trials

Authors
JM Unger;R Vaidya;K Albain;M Leblanc;L Minasian;C Gotay;NL Henry;M Fisch;S Ramsey;CD Blanke;D Hershman
Journal / Conference
J Clin Oncol 37(suppl; abstr 11588); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), poster session
Year
2019
Research Committee(s)
Cancer Care Delivery and Symptom Management and Survivorship

The Impact of NCI-Sponsored Network Group Clinical Trials on Guideline Care and New Drug Indications

Authors
J Unger;V Nghiem;DL Hershman;R Vaidya;M Leblanc;CD Blanke
Journal / Conference
J Clin Oncol 37(suppl; abstr 6604); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), poster session
Year
2019
Research Committee(s)
Cancer Care Delivery

The Association of Baseline Cardiovascular Risk Factors and Healthcare Utilization and Costs in Elderly Breast Cancer Patients Enrolled in SWOG Clinical Trials

Authors
D Hershman;C Till;J Wright;M Accordino;R Vaidya;W Barlow;S Ramsey;J Unger
Journal / Conference
J Clin Oncol 37(suppl; abstr 11508); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Cancer Care Delivery

Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)

Authors
E Bergsland;M Mahoney;T Asmis;N Hall;P Kumthekar;M Maitland;D Niedzwiecki;AB Nixon;EM O'Reilly;LH Schwartz;JA Sloan;J Strosberg;J Meyerhardt
Journal / Conference
J Clin Oncol 37(suppl; abstr 4005); American Society of Clinical Oncology (5/31 - 6/4/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021202

Results of Alliance A031201: A Phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for men with metastatic castration resistant prostate cancer (mCRPC)

Authors
MJ Morris;G Heller;A Bryce;A Armstrong;H Beltram;O Hahn;E McGary;P Mehan;A Goldkorn;B Roth;H Xiao;ME Taplin;CJ Ryan;S Halabi;E Small
Journal / Conference
J Clin Oncol 37(suppl; abstr 5008); American Society of Clinical Oncology (5/31/2-6/4/19, Chicago IL), oral
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/A031201

Alliance A091404: A Phase II Study of ENZALUTAMIDE (NSC# 766085) for Patients with Androgen Receptor Positive Salivary Cancers

Authors
AL Ho;NR Foster;AJ Zoroufry;FP Worden;K Price;D Adkins;D Bowles;H Kang;B Burtness;E Sherman;R Morton;N Katabi;P Munster
Journal / Conference
J Clin Oncol 37(suppl; abstr 6020); American Society of Clinical Oncology (5/31-6/4/19, Chicago IL), poster discussion
Year
2019

CALGB/Alliance 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) (+/- carboplatin (Cb) and bevacizumab (Bev)) in triple-negative breast cancer (TNBC)

Authors
W Sikov;M-Y Polley;E Twohy;C Perou;B Singh;DA Berry;S Tolaney;G Somlo;E Port;R Qamar;K Sturtz;E Mamounas;M Golshan;J Bellon;D Collyar;O Hahn;C Hudis;E Winer;A Partridge;L Carey
Journal / Conference
J Clin Oncol 37(suppl; abstr 591); American Society of Clinical Oncology (5/31-6/4/19, Chicago IL), poster session
Year
2019
Research Committee(s)
Breast
Study Number(s)
CTSU/C40603

CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC)

Authors
JA Eastham;G Heller;S Halabi;P Monk;SK Clinton;R Zelig Szmulewitz;J Coleman;M Gleave;CP Evans;CW Hillman;H Beltran;ME Taplin;OM Hahn;JK Parsons;EJ Small;J Mohler;MJ Morris
Journal / Conference
J Clin Oncol 37(suppl; abstr 5079; American Society of Clinical Oncology (5/31-6/4/19, Chicago IL), poster session
Year
2019
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/C90203